Statement regarding death of Ellen Raffell
20th January 2021
We are saddened to learn of the tragic death of Ellen Raffell, aged 16, who sadly died on 31st October 2019. We would like to offer our deepest sympathies to her family at this difficult time. Following the inquest on Monday 18th January 2021. It has been reported that Ellen went into cardiac arrest which […]
Read More...Does your child have peanut allergy?
8th January 2021
Have they taken part or are they taking part in a peanut protein powder clinical trial? Acaster Lloyd Consulting are looking for participants to take part in a research study about caregivers’ and children’s experiences of an oral peanut protein powder (immunotherapy) treatment. What does it involve? This study will involve completing an online survey […]
Read More...European Commission approves first treatment for peanut allergy
7th January 2021
Aimmune Therapeutics’ PALFORZIA® has been approved by the European Commission as a treatment for peanut allergy. The European Commission (EC) has approved PALFORZIA® for the treatment of peanut allergy, making it the first treatment for the condition. Produced by Aimmune Therapeutics, a Nestlé Health Science Company, PALFORZIA is indicated in patients aged four to 17 […]
Read More...Allergy Therapeutics and Imperial College London start Peanut Allergy Study
6th January 2021
Allergy Therapeutics PLC – Sussex-based biotechnology firm focused on allergy vaccines – Initiates peanut allergy biomarker study with Imperial College London to confirm potential of novel peanut vaccine candidate. The study aims to evaluate the novel virus like particle based peanut allergy vaccine candidate, to confirm its hypoallergic potential and its potent immune response. Submission […]
Read More...Entrepreneur and allergy advocate Julianne Ponan is named Anaphylaxis Campaign’s newest ambassador
16th December 2020
The Anaphylaxis Campaign, the only UK-wide charity operating solely for the growing numbers of people at risk from severe allergic reactions, has welcomed a new Ambassador to help raise awareness and create a safer environment for those with allergies. Julianne Ponan, who is well known amongst the allergic community as a professional speaker and founder of […]
Read More...MHRA statement on guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination
10th December 2020
Dr June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said: “We have this evening (Wednesday 9 December 2020) issued updated guidance to COVID-19 vaccination centres about the management of anaphylaxis, following two reports of anaphylaxis and one report of a possible allergic reaction following immunisation. This guidance confirms the precautionary […]
Read More...Statement regarding the inquest of Muhammed Musa Akbar
24th November 2020
Derby Coroner’s Court has ended the inquest into the death of Muhammed Musa Akbar, (known as Musa) a 12-year-old boy who died on 15 January 2019 after suffering a suspected severe allergic reaction whilst at a football birthday party at Powerleague in Derby. The court was told Musa had a history of asthma and a […]
Read More...LOVE ISLAND’s Jack Fowler joins ‘Break the Stigma’ campaign to empower young people with life-threatening allergies
23rd November 2020
The May Contain Break the Stigma campaign empowers young people to speak up about their allergies and feel confident addressing them throughout their lives. The campaign features inspiring allergy advocates from TV, theatre, sport, and news. LINK TO THE HERO IMAGES – https://we.tl/t-ttjNFzbFly Daniel Kelly, 27, founded May Contain, an allergy awareness and lifestyle platform, in […]
Read More...Wellingborough and Chester restaurants fined after customers suffer severe allergic reactions
18th November 2020
In two unrelated incidents, two restaurant owners have received substantial court fines this month, following successful prosecutions after their customers suffered severe allergic reactions as a result of being served their allergens in error. In Wellingborough, a woman had called the Akash Tandoori last June to order a takeaway for her family, including her 19-year-old […]
Read More...DBV Technologies announces filing and validation of marketing authorization application for Viaskin™ Peanut by European Medicines Agency
17th November 2020
DBV Technologies, a biopharmaceutical company and Corporate Member of the Campaign, announced on November 5 that its product Viaskin™ Peanut (DBV712) has been validated by the European Medicines Agency (EMA). The validation confirms that the submission is sufficiently complete to begin the formal review process for the investigational non-invasive, once-daily epicutaneous patch to treat peanut […]
Read More...